Browsing Tag

slumps

Laurus Labs Q4 net slumps

Drugmaker Laurus Labs’ consolidated net profit slumped almost 54% for the March quarter to ₹107.24 crore as revenue from the key generic FDF and CDMO-Synthesis business segments were lower compared to the year earlier period.Revenue from…